Victoria’s Secret Stock Soaring And Ozempic Could Be Responsible For Turnaround

(Photo by Tim P. Whitby/Getty Images)

Women are flocking back to Victoria’s Secret.

It has little to do with clever marketing, as many have suggested. Simply put: It’s probably the Ozempic. 

Victoria’s Secret shares spiked about 50% Tuesday, according to Reuters — marking a record high for the 49-year-old lingerie retailer. Victoria’s Secret stock has “nearly tripled in value” in the past year, Reuters reports.

Reuters notes that CEO Hillary Super, appointed to the role in 2024, has directed the company to (re)embrace sex appeal. (RELATED: Victoria’s Secret Trying Best Not To Be Next Cracker Barrel) 

Super told Fortune in February that “performative” displays of diversity “lack........

© The Daily Caller